Skip to main content

Hemolytic-Uremic Syndrome clinical trials at UCSF

1 research study open to eligible people

Hemolytic-uremic syndrome is a rare illness that harms the blood and kidneys. UCSF is conducting a study to test Crovalimab in people with atypical hemolytic-uremic syndrome. The research focuses on the drug's safety and how it affects the body.

Showing trials for

Last updated: